Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$39.75 USD
+0.87 (2.24%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $39.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: BMO |
6/2024 | $-0.32 | 26.98% |
Earnings Summary
For their last quarter, Apellis Pharmaceuticals (APLS) reported earnings of -$0.54 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for APLS's next earnings release on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.32 per share, reflecting a year-over-year increase of 68.63%.
Earnings History
Price & Consensus
Zacks News for APLS
Apellis' (APLS) Syfovre Boost Sales, Regulatory Setbacks a Woe
APLS: What are Zacks experts saying now?
Zacks Private Portfolio Services